Anti-Phospho-SHIP (Y1020) Antibody [JJ082-03]

HUABIO

Anti-Phospho-SHIP (Y1020) Antibody [JJ082-03]

7

ImmunoFluorescence, ImmunoPrecipitation, Western Blot

WB,IF-Cell,IP

Research Use Only

Monoclonal

JJ082-03

1 mg/ml

Unconjugated

INPP5D

inositol polyphosphate-5-phosphatase D

SHIP, SHIP-1, SHIP1, SIP-145, hp51CN, p150Ship, phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1, SH2 domain-containing inositol 5'-phosphatase 1, inositol polyphosphate-5-phosphatase, 145kD, inositol polyphosphate-5-phosphatase, 145kDa, phosphatidylinositol 4,5-bisphosphate 5-phosphatase, signaling inositol polyphosphate 5 phosphatase SIP-145, signaling inositol polyphosphate phosphatase SHIP II

Rabbit

IgG

Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1

The major translational product of the v-Fms oncogene, originally isolated from the McDonough strain of feline sarcoma virus, has been identified as a glycoprotein with intrinsic tyrosine kinase activity. The v-Fms human cellular homolog, c-Fms, has been molecularly cloned and mapped to band q34 on chromosome 5, and identified as the receptor for hematopoietic ligand, CSF-1. Ligand-induced activation of the intrinsic CSF-1R protein tyrosine kinase triggers its interaction with cytoplasmic effector molecules. One such effector molecule, SHIP-1 p145 (SH2-containing-inositol phosphatase), associates with activated Fms. SHIP-1 contains two phosphotyrosine-binding domains (PTB), a unique amino terminal SH2 domain, a proline-rich region, and two highly conserved motifs found among inositol phosphate 5-phosphatases. SHIP-1 displays both phosphatidylinositol 3,4,5-triphosphate and inositol 1,3,4,5-tetrakisphosphate polyphosphate 5-phosphatase activity. Evidence suggests that SHIP-1 may modulate Ras signaling in addition to inositol signaling pathways.

Human

Human

-20°C,2°C to 8°C

41116161